Verification of a Novel Minimally Invasive Device for the Isolation of Rare Circulating Tumor Cells (CTC) in Cancer Patients’ Blood

SIMPLE SUMMARY: Detection of circulating tumor cells (CTCs) in blood can be used to diagnose cancer or monitor treatment response for various cancers. However, these cells are rare in the bloodstream in the early stages of cancers, and it, therefore, remains a technical challenge to isolate them. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Geus, Paul Friedrich, Hehnen, Felix, Krakowski, Sophia, Lücke, Klaus, Hoon, Dave S. B., Frost, Nikolaj, Kertzscher, Ulrich, Wendt, Gabi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562020/
https://www.ncbi.nlm.nih.gov/pubmed/36230675
http://dx.doi.org/10.3390/cancers14194753

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562020/
https://www.ncbi.nlm.nih.gov/pubmed/36230675
http://dx.doi.org/10.3390/cancers14194753

Ejemplares similares